Sanibel Captiva Trust Company’s AstraZeneca AZN Stock Holding History

Sanibel Captiva Trust Company’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,392	Closed	-$1.91M	–	438
2025 Q4	$1.91M	Buy	10,392 +693	+7%	+$122K	0.05%	182
2025 Q3	$1.49M	Buy	9,699 +461	+5%	+$69.8K	0.04%	201
2025 Q2	$1.29M	Buy	9,238 +217	+2%	+$30.4K	0.04%	205
2025 Q1	$1.33M	Sell	9,021 -782	-8%	-$113K	0.04%	201
2024 Q4	$1.28M	Buy	9,803 +739	+8%	+$103K	0.04%	202
2024 Q3	$1.41M	Buy	9,064 +336	+4%	+$54.2K	0.05%	194
2024 Q2	$1.36M	Sell	8,728 -396	-4%	-$59.6K	0.05%	186
2024 Q1	$1.24M	Buy	9,124 +126	+1%	+$16.7K	0.04%	189
2023 Q4	$1.21M	Buy	+8,998	New	+$1.17M	0.04%	178

Other funds holding AZN

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Asset Management London, Ec4n 8af $148B AUM

Sanibel Captiva Trust Company's AZN Position: Q1 2026 in Review

Sanibel Captiva Trust Company sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 10,392 shares — an estimated $1.91M sold.

Sanibel Captiva Trust Company first reported a position in AZN in Q4 2023 and held it in 9 quarters. The position peaked at $1.91M in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Sanibel Captiva Trust Company reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Sanibel Captiva Trust Company sold 10,392 AstraZeneca shares in Q1 2026, an estimated $1.91M.
Sanibel Captiva Trust Company first reported a position in AstraZeneca in Q4 2023 and held it in 9 quarters.
Sanibel Captiva Trust Company's AstraZeneca position peaked at $1.91M in Q4 2025.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Sanibel Captiva Trust Company's 13F filing for Q1 2026, filed 15 May 2026.